MW 464.9 Da, Purity >99%. Potent, selective 5-HT2C receptor antagonist (Ki = 1 nM). Neurological agent. Active *in vivo* and *in vitro*.
AIS, ANDR_HUMAN, AR, AR8, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease), Atherosclerosis, susceptibility to, included, BXR, DHTR, DKFZp686N23123, Dihydro testosterone receptor, Dihydrotestosterone receptor (DHTR), ER, ER-alpha, ER-beta, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESRA, ESRL 1, ESRR A, ESTR B, Era, Erb, Erb2, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta 4, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen resistance, included, Estrogen-related receptor alpha, Estrra, HDL cholesterol, augmented response of, to hormone replacement, included, HUMARA, HYSP1, KD, Kennedy disease (KD), Myocardial infarction, susceptibility to, included, NF-E2-related factor 2, NF2L2_HUMAN, NR1I2_HUMAN, NR3A1, NR3A2, NR3B1, NR3C4, NRF2, Nfe2l2, Nuclear factor, Nuclear factor (erythroid derived 2) like 2, Nuclear factor erythroid 2-related factor 2, Nuclear factor erythroid derived 2 like 2, Nuclear receptor subfamily 1 group I member 2, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, Nuclear receptor subfamily 3 group B member 1, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), ONR 1, OTTHUMP00000017718, OTTHUMP00000017719, OTTHUMP00000215173, OTTHUMP00000215174, OTTHUMP00000215175, Orphan nuclear receptor PAR 1, Orphan nuclear receptor PXR, PAR, PAR q, PRR, Pregnane X receptor, RNESTROR, SBMA, SMAX1, SXR, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), Steroid and xenobiotic receptor, Steroid hormone receptor ERR1, TFM, Testicular Feminization (TFM), androgen receptor splice variant 4b, erythroid derived 2, estrogen receptor related receptor alpha, hERR1, like 2, nuclear factor erythroid 2 like 2, pregnane X nuclear receptor variant 2
MW 464.9 Da, Purity >99%. Potent, selective 5-HT2C receptor antagonist (Ki = 1 nM). Neurological agent. Active *in vivo* and *in vitro*.
Soluble in DMSO to 50 mM.
Soluble in ethanol to 100 mM.
Potent, selective 5-HT2C receptor antagonist (Ki = 1 nM). Neurological agent. Active *in vivo* and *in vitro*.
Estrogen Receptor (ER) Androgen Receptor (AR) Pregnane X Receptor (PXR) Estrogen Related Receptor Alpha (ERRα) and Nuclear factor erythroid 2–related factor 2 (Nrf2) play critical roles in cellular regulation. ER and AR are nuclear hormone receptors with respective alternate names NR3A1 and NR3C4. Both receptors typically have molecular weights around 66 kDa for ER and 110 kDa for AR and are expressed widely in tissues related to their function such as breast ovarian and prostate tissues. PXR also known as NR1I2 regulates various genes involved in metabolism and detoxification primarily in the liver and intestines. ERRα although similar in nomenclature does not bind estrogen but acts as a transcriptional regulator in energy metabolism. Nrf2 functions as a transcription factor in response to oxidative stress and is ubiquitously expressed.
These receptors and transcription factors orchestrate significant molecular functions. ER and AR modulate gene transcription upon binding their respective ligands estrogen and testosterone. Part of their function includes forming complexes with other co-regulators. PXR integrates metabolism-related gene expression impacting drug metabolism by forming a regulatory network with other nuclear receptors. ERRα influences mitochondrial biogenesis and function integrating energy homeostasis. Nrf2 responds to oxidative stress by dissociating from Keap1 then translocating to the nucleus to activate antioxidant response elements (ARE).
ER and AR are integral to hormone signaling pathways. ER interacts within the estrogen-signaling pathway influencing proteins such as coactivators and corepressors. AR is active in the androgen receptor signaling pathway involving direct androgenic signaling and crosstalk with other pathways such as the Wnt signaling pathway. PXR plays a role in the nuclear receptor signaling pathways related to xenobiotic metabolism which involves the CYP3A4 enzyme and impacts detoxification processes. ERRα is linked to pathways regulating cellular energy metabolism interacting with proteins such as PGC-1α. Nrf2 fits into the KEAP1-NRF2-ARE pathway essential for mediating the antioxidant response.
ER is linked primarily to breast cancer due to its role in estrogen signaling while AR is associated with prostate cancer both involving altered receptor function and related proteins such as co-regulators. PXR plays a part in drug-induced liver injury particularly where metabolism perturbs normal function related to enzymes like CYP3A4. ERRα is implicated in metabolic disorders like obesity where altered expression affects metabolic homeostasis. Nrf2 is associated with neurodegenerative diseases notably Parkinson’s disease as oxidative stress plays a big role. Abnormal Nrf2 activity affects antioxidants and proteins connected to cellular stress responses.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab141291, SB 243213 dihydrochloride, 5HT2C receptor antagonist
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com